Protective overweight in cardiovascular disease: moving from ‘paradox’ to ‘paradigm’

Cardiovascular risk in relation to body mass index and use of evidence-based preventive medications in patients with or at risk of atherothrombosis

(2015) Boris Hansel et al.   EUROPEAN HEART JOURNAL

Critical appraisal of the obesity paradox in cardiovascular disease: How to manage patients with overweight in heart failure?

(2014) Wolfram Doehner   HEART FAILURE REVIEWS

Metabolic Impairment in Heart Failure

(2014) Wolfram Doehner et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014

(2014) John E. Morley et al.   Journal of Cachexia Sarcopenia and Muscle

Skeletal myopathy in patients with chronic heart failure: significance of anabolic-androgenic hormones

(2014) Krystian Josiak et al.   Journal of Cachexia Sarcopenia and Muscle

Osteosarcopenic obesity: the role of bone, muscle, and fat on health

(2014) Michael J. Ormsbee et al.   Journal of Cachexia Sarcopenia and Muscle

Cachexia vs obesity: where is the real unmet clinical need?

(2013) Stephan von Haehling et al.   Journal of Cachexia Sarcopenia and Muscle

Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies

(2012) Stuart J. Pocock et al.   EUROPEAN HEART JOURNAL